Skip to content
Recall Observatory FDA recall evidence

Drug product

Lisdexamfetamine Dimesylate Capsules, 10 mg, 100 Capsules per bottle, Rx only, Distributed by: Lannet Company, Philadelphia, PA 19136, NDC: 0527-4661-37

D-0112-2025

October 25, 2024

Class II

Product summary

Firm
Lannett Company Inc.
Event
Event 95630
Status
Terminated
Classification
Class II
Quantity
1608 bottles
Official record key
drug-enforcement:D-0112-2025

Official wording

Reason: Failed Content Uniformity Specifications: Product failed to meet the action limits for stratified content uniformity.

Code information: Lot: 23274856A, Exp 04/30/2025

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Content Uniformity Specifications